58
https://pubmed.ncbi.nlm.nih.gov/38116434
Researchers have identified inhibitory peptides that suppress the formation of toxic fibrils in mutant Huntingtin proteins associated with Huntington’s disease, providing a potential therapeutic lead for further optimization and development.